REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 167 filers reported holding REPLIGEN CORP in Q3 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,267,656 | +33.7% | 20,550 | +19.0% | 0.14% | +41.2% |
Q2 2023 | $2,443,439 | -62.0% | 17,273 | -88.9% | 0.10% | -77.6% |
Q2 2017 | $6,427,000 | +20.7% | 155,099 | +2.5% | 0.43% | +18.6% |
Q1 2017 | $5,326,000 | -6.8% | 151,298 | -18.4% | 0.36% | -13.3% |
Q4 2016 | $5,714,000 | -1.7% | 185,402 | -3.7% | 0.42% | -2.8% |
Q3 2016 | $5,813,000 | +10.1% | 192,549 | -0.2% | 0.43% | +4.1% |
Q2 2016 | $5,278,000 | +30.2% | 192,911 | +27.6% | 0.42% | +13.4% |
Q1 2016 | $4,054,000 | -5.3% | 151,160 | -0.1% | 0.37% | -5.2% |
Q4 2015 | $4,281,000 | +2.0% | 151,333 | +0.4% | 0.39% | -4.2% |
Q3 2015 | $4,199,000 | -16.8% | 150,756 | +23.3% | 0.40% | -13.3% |
Q2 2015 | $5,046,000 | -18.9% | 122,263 | -40.4% | 0.47% | -13.1% |
Q1 2015 | $6,224,000 | +149.3% | 205,022 | +62.6% | 0.54% | +90.7% |
Q4 2014 | $2,497,000 | +61.2% | 126,120 | +62.1% | 0.28% | +32.5% |
Q3 2014 | $1,549,000 | +10.6% | 77,799 | +26.6% | 0.21% | +6.5% |
Q2 2014 | $1,400,000 | – | 61,430 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |